AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CHARLOTTETOWN, P.E.I -- Vaginal stenosis is a common compli cation after pelvic and vaginal radiotherapy that occurs in 38% of patients, but physicians are not being proactive about promoting vaginal dilation therapy to counteract the problem, according to an Australian physician.
"In the past we have been so concerned about curing the patients of the cancer, but as we get better and better at that we really need to focus on the side effects," said Dr Alison Brand of the department of gynecological oncology at Westmead Hospital in Sydney, Australia.
"In the past, we have focused on bladder and bowel problems related to radiotherapy, and I think the time has come now to focus on other things, such as vaginal problems, because that has a huge impact on patients' quality of life," she said at the annual clinical meeting of the Society of Obstetricians and Gynecologists of Canada.
Dr. Brand outlined her study of 188 patients with cervical cancer who had received radical pelvic radiotherapy and/or vaginal brachytherapy as part of their treatment.
Patients were graded on a scale of 0-4, with grade 0 being no vaginal toxicity and flimsy adhesions and grade 4 being fistula to the bladder, bowel, or peritoneal area. A total of 27% of patients had grade 1 (or partial) vaginal stenosis, and 11% had grade 2 (complete stenosis).
In analyzing risk factors for vaginal stenosis after pelvic radiotherapy, the researchers concluded that women ...